Symbiorph Clinical Trialogy has capability to support a wide range of global and national Phase I - IV clinical trials in various therapeutic areas.

For the early stages of drug development i.e.; First-In-Man (FIM) and exploratory development a studies including proof of concept, Symbiorph Clinical Trialogy provides detailed overview of key aspects involved during the commencing of the trial. Our approach is to delivers quality and reliable results by controlling the cost and time.

In early phase projects, Symbiorph Clinical Trialogy typically provides the full range of services including study and protocol design, clinical project management, clinical monitoring, regulatory submission, data management, and biostatistics services.

As products progress through clinical development to phases III and IV, regulatory requirements grow becoming critical and costly to market release for drugs and medical devices. The studies become larger and the organizational and logistical challenges increase. Our team has proven solution to manage thousands of subjects in phases III and IV studies to determine additional safety information, or pharmacovigilance, regarding the risks, benefits, and optimal usage of drugs and medical devices.